Dual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastoma

Published:2020-02-08 Issue:3 Volume:111 Page:940-950
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ke Chao¹²³,Luo Jun‐ran¹²³,Cen Zi‐wen¹²³,Li Yanyan⁴,Cai Hai‐ping¹²³,Wang Jing¹²³^ORCID,Chen Fu‐rong¹²³,Siegel Eric R.⁵,Le Kody N.⁶,Winokan Jesica R.⁶,Gibson Grace J.⁶,McSwain Asia E.⁶,Afrasiabi Kambiz⁶,Linskey Mark E.⁶,Zhou You‐Xin⁴,Chen Zhong‐ping¹²³,Zhou Yi‐Hong⁶^ORCID

Affiliation:

1. Department of Neurosurgery Sun Yat‐sen University Cancer Center Guangzhou China

2. State Key Laboratory of Oncology in South China Guangzhou China

3. Collaborative Innovation Center for Cancer Medicine Guangzhou China

4. Neurosurgery and Brain and Nerve Research Laboratory The First Affiliated Hospital of Soochow University Suzhou China

5. Department of Biostatistics University of Arkansas for Medical Sciences Little Rock AR USA

6. Department of Neurological Surgery Brain Tumor Research Laboratory University of California Irvine CA USA

Funder

Musella Foundation For Brain Tumor Research and Information

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14300

Reference26 articles.

1. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

2. Cell context-dependent dual effects of EFEMP1 stabilizes subpopulation equilibrium in responding to changes of in vivo growth environment

3. Extracellular control of chromosomal instability and maintenance of intra-tumoral heterogeneity

4. Weaponizing human EGF‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics;Zhou YH;Oncoscience,2016

5. Human fibulin‐3 protein variant expresses anti‐cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models;Li Y;Oncotarget,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secreted clusterin inhibits tumorigenesis by modulating tumor cells and macrophages in human meningioma;Neuro-Oncology;2024-02-28

2. EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt/β-catenin and TGF-β/Smad2/3 signal pathways;Journal of Bone Oncology;2022-12

3. Glioblastoma Vasculature: From its Critical Role in Tumor Survival to Relevant in Vitro Modelling;Frontiers in Drug Delivery;2022-02-17

4. Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease;Cancers;2020-06-22

5.

Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?

;OncoTargets and Therapy;2020-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3